Log in to save to my catalogue

Meningoencephalitis from Borrelia miyamotoi in an Immunocompromised Patient

Meningoencephalitis from Borrelia miyamotoi in an Immunocompromised Patient

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4018741

Meningoencephalitis from Borrelia miyamotoi in an Immunocompromised Patient

About this item

Full title

Meningoencephalitis from Borrelia miyamotoi in an Immunocompromised Patient

Publisher

Waltham, MA: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2013-01, Vol.368 (3), p.240-245

Language

English

Formats

Publication information

Publisher

Waltham, MA: Massachusetts Medical Society

More information

Scope and Contents

Contents

Borrelia miyamotoi
was found to be the causative agent of mental decline in an older patient who underwent treatment with rituximab for non-Hodgkin's lymphoma.
Summary
Ixodes ticks serve as vectors for
Borrelia burgdorferi,
the agent of Lyme disease. Globally, these ticks often concurrently harbor
B. miyamotoi,
a spirochete tha...

Alternative Titles

Full title

Meningoencephalitis from Borrelia miyamotoi in an Immunocompromised Patient

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4018741

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4018741

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1209039

How to access this item